Both in Pharmaceuticals
TransCode Therapeutics vs IGC Pharma
Over the past year RNAZ returned −84.7% and IGC returned −36.3%; their daily moves had a correlation of 0.11.
RNAZ −84.7% IGC −36.3%Growth of $1, one year, split-adjusted
| Metric | RNAZ | IGC |
|---|---|---|
| Price | $1.63 | $0.2675 |
| Market cap | $27.6M | $27.7M |
| Today | −4.68% | −2.37% |
| 1 month | −25.2% | −13.7% |
| 6 months | −81.0% | +4.7% |
| Year to date | −76.1% | −4.9% |
| 1 year | — | −32.7% |
| Revenue growth (YoY) | — | −19.2% |
| Gross margin | — | 18.1% |
| Net margin | — | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 98.5% | 51.4% |
| Short % of float | 7.1% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).